415 related articles for article (PubMed ID: 33193951)
1. Very severe COVID-19 in the critically ill in Tunisia.
Saida IB; Ennouri E; Nachi R; Meddeb K; Mahmoud J; Thabet N; Jerbi S; Boussarsar M
Pan Afr Med J; 2020; 35(Suppl 2):136. PubMed ID: 33193951
[TBL] [Abstract][Full Text] [Related]
2. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.
Grasselli G; Zangrillo A; Zanella A; Antonelli M; Cabrini L; Castelli A; Cereda D; Coluccello A; Foti G; Fumagalli R; Iotti G; Latronico N; Lorini L; Merler S; Natalini G; Piatti A; Ranieri MV; Scandroglio AM; Storti E; Cecconi M; Pesenti A;
JAMA; 2020 Apr; 323(16):1574-1581. PubMed ID: 32250385
[TBL] [Abstract][Full Text] [Related]
3. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.
Yang X; Yu Y; Xu J; Shu H; Xia J; Liu H; Wu Y; Zhang L; Yu Z; Fang M; Yu T; Wang Y; Pan S; Zou X; Yuan S; Shang Y
Lancet Respir Med; 2020 May; 8(5):475-481. PubMed ID: 32105632
[TBL] [Abstract][Full Text] [Related]
4. Experience in the management of severe COVID-19 patients in an intensive care unit.
Sosa-García JO; Gutiérrez-Villaseñor AO; García-Briones A; Romero-González JP; Juárez-Hernández E; González-Chon O
Cir Cir; 2020; 88(5):569-575. PubMed ID: 33064694
[TBL] [Abstract][Full Text] [Related]
5. IMPACT OF COMORBIDITIES IN MEXICAN SARS-COV-2-POSITIVE PATIENTS: A RETROSPECTIVE ANALYSIS IN A NATIONAL COHORT.
Kammar-García A; Vidal-Mayo JJ; Vera-Zertuche JM; Lazcano-Hernández M; Vera-López O; Segura-Badilla O; Aguilar-Alonso P; Navarro-Cruz AR
Rev Invest Clin; 2020; 72(3):151-158. PubMed ID: 32584330
[TBL] [Abstract][Full Text] [Related]
6. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
Cummings MJ; Baldwin MR; Abrams D; Jacobson SD; Meyer BJ; Balough EM; Aaron JG; Claassen J; Rabbani LE; Hastie J; Hochman BR; Salazar-Schicchi J; Yip NH; Brodie D; O'Donnell MR
Lancet; 2020 Jun; 395(10239):1763-1770. PubMed ID: 32442528
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 in Spanish Intensive Care Units: Early experience with 15-day survival in Vitoria.
Barrasa H; Rello J; Tejada S; Martín A; Balziskueta G; Vinuesa C; Fernández-Miret B; Villagra A; Vallejo A; San Sebastián A; Cabañes S; Iribarren S; Fonseca F; Maynar J;
Anaesth Crit Care Pain Med; 2020 Oct; 39(5):553-561. PubMed ID: 32278670
[TBL] [Abstract][Full Text] [Related]
8. Norwegian Coronavirus Disease 2019 (NO COVID-19) Pragmatic Open label Study to assess early use of hydroxychloroquine sulphate in moderately severe hospitalised patients with coronavirus disease 2019: A structured summary of a study protocol for a randomised controlled trial.
Lyngbakken MN; Berdal JE; Eskesen A; Kvale D; Olsen IC; Rangberg A; Jonassen CM; Omland T; Røsjø H; Dalgard O
Trials; 2020 Jun; 21(1):485. PubMed ID: 32503662
[TBL] [Abstract][Full Text] [Related]
9. Clinical Characteristics and Outcomes of Hospitalized and Critically Ill Children and Adolescents with Coronavirus Disease 2019 at a Tertiary Care Medical Center in New York City.
Chao JY; Derespina KR; Herold BC; Goldman DL; Aldrich M; Weingarten J; Ushay HM; Cabana MD; Medar SS
J Pediatr; 2020 Aug; 223():14-19.e2. PubMed ID: 32407719
[TBL] [Abstract][Full Text] [Related]
10. Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.
Grasselli G; Greco M; Zanella A; Albano G; Antonelli M; Bellani G; Bonanomi E; Cabrini L; Carlesso E; Castelli G; Cattaneo S; Cereda D; Colombo S; Coluccello A; Crescini G; Forastieri Molinari A; Foti G; Fumagalli R; Iotti GA; Langer T; Latronico N; Lorini FL; Mojoli F; Natalini G; Pessina CM; Ranieri VM; Rech R; Scudeller L; Rosano A; Storti E; Thompson BT; Tirani M; Villani PG; Pesenti A; Cecconi M;
JAMA Intern Med; 2020 Oct; 180(10):1345-1355. PubMed ID: 32667669
[TBL] [Abstract][Full Text] [Related]
11. Respiratory Support in Severely or Critically Ill ICU Patients With COVID-19 in Wuhan, China.
Hu HT; Xu S; Wang J; Rao X
Curr Med Sci; 2020 Aug; 40(4):636-641. PubMed ID: 32767265
[TBL] [Abstract][Full Text] [Related]
12. Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.
Shen C; Wang Z; Zhao F; Yang Y; Li J; Yuan J; Wang F; Li D; Yang M; Xing L; Wei J; Xiao H; Yang Y; Qu J; Qing L; Chen L; Xu Z; Peng L; Li Y; Zheng H; Chen F; Huang K; Jiang Y; Liu D; Zhang Z; Liu Y; Liu L
JAMA; 2020 Apr; 323(16):1582-1589. PubMed ID: 32219428
[TBL] [Abstract][Full Text] [Related]
13. A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial.
Smith K; Pace A; Ortiz S; Kazani S; Rottinghaus S
Trials; 2020 Jul; 21(1):639. PubMed ID: 32660611
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of hospitalised patients with COVID-19 and chronic inflammatory and autoimmune rheumatic diseases: a multicentric matched cohort study.
Pablos JL; Galindo M; Carmona L; Lledó A; Retuerto M; Blanco R; Gonzalez-Gay MA; Martinez-Lopez D; Castrejón I; Alvaro-Gracia JM; Fernández Fernández D; Mera-Varela A; Manrique-Arija S; Mena Vázquez N; Fernandez-Nebro A; ;
Ann Rheum Dis; 2020 Dec; 79(12):1544-1549. PubMed ID: 32796045
[TBL] [Abstract][Full Text] [Related]
16. Determinants of COVID-19 disease severity in patients with underlying rheumatic disease.
Santos CS; Morales CM; Álvarez ED; Castro CÁ; Robles AL; Sandoval TP
Clin Rheumatol; 2020 Sep; 39(9):2789-2796. PubMed ID: 32720259
[TBL] [Abstract][Full Text] [Related]
17. Characteristics, complications and outcomes among 1549 patients hospitalised with COVID-19 in a secondary hospital in Madrid, Spain: a retrospective case series study.
Jiménez E; Fontán-Vela M; Valencia J; Fernandez-Jimenez I; Álvaro-Alonso EA; Izquierdo-García E; Lazaro Cebas A; Gallego Ruiz-Elvira E; Troya J; Tebar-Martinez AJ; Garcia-Marina B; Peña-Lillo G; Abad-Motos A; Macaya L; Ryan P; Pérez-Butragueño M; ;
BMJ Open; 2020 Nov; 10(11):e042398. PubMed ID: 33172949
[TBL] [Abstract][Full Text] [Related]
18. Clinical Characteristics and Morbidity Associated With Coronavirus Disease 2019 in a Series of Patients in Metropolitan Detroit.
Suleyman G; Fadel RA; Malette KM; Hammond C; Abdulla H; Entz A; Demertzis Z; Hanna Z; Failla A; Dagher C; Chaudhry Z; Vahia A; Abreu Lanfranco O; Ramesh M; Zervos MJ; Alangaden G; Miller J; Brar I
JAMA Netw Open; 2020 Jun; 3(6):e2012270. PubMed ID: 32543702
[TBL] [Abstract][Full Text] [Related]
19. Cohort of Four Thousand Four Hundred Four Persons Under Investigation for COVID-19 in a New York Hospital and Predictors of ICU Care and Ventilation.
Singer AJ; Morley EJ; Meyers K; Fernandes R; Rowe AL; Viccellio P; Thode HC; Bracey A; Henry MC
Ann Emerg Med; 2020 Oct; 76(4):394-404. PubMed ID: 32563601
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Epidemiological Features of SARS-CoV-2 Patients in SARI Ward of a Tertiary Care Centre in New Delhi.
Aggarwal A; Shrivastava A; Kumar A; Ali A
J Assoc Physicians India; 2020 Jul; 68(7):19-26. PubMed ID: 32602676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
